Contract AcquisitionA material new contract with AZN was signed, focused on developing an AI model in difficult breast cancers.
Customer GrowthMomentum appears to be building as volume grew with 33 new core genomics customers implemented.
Market ExpansionUS market expansion continues, where revenue and volumes grew over 30%, indicating strong market penetration.